Schedule 13D ownership disclosure
KalVista Pharmaceuticals Inc
Security class unavailable · CUSIP: 483497103
Event date: 2016-11-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 29.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-780945
- Form type
- SC 13D
- Filer
- KalVista Pharmaceuticals, Inc.
- CIK
- CIK 1348911
- Filed
- Nov 30, 2016
- Reporting period
- Nov 21, 2016
- Description
- Schedule 13D beneficial ownership